| Ident. | Authors (with country if any) | Title |
|---|
| 000243 (2016) |
Edith Miville-Godbout [Canada] ; Mélanie Bourque [Canada] ; Marc Morissette [Canada] ; Sara Al-Sweidi [Canada] ; Tara Smith [Canada] ; Asuka Mochizuki [Canada, Japon] ; Vijitha Senanayake [Canada] ; Dushmanthi Jayasinghe [Canada] ; Li Wang [Canada] ; Dayan Goodenowe [Canada] ; Thérèse Di Paolo [Canada] | Plasmalogen Augmentation Reverses Striatal Dopamine Loss in MPTP Mice |
| 000262 (2016) |
Julieta E. Arena [Canada] ; A Jon Stoessl [Canada] | Optimizing diagnosis in Parkinson's disease: Radionuclide imaging. |
| 000273 (2016) |
Mohammed Filali [Canada] ; Robert Lalonde [France] | Neurobehavioral Anomalies in the Pitx3/ak Murine Model of Parkinson's Disease and MPTP. |
| 000314 (2016) |
F. Pieruccini-Faria [Canada] ; J A Jones [Canada] ; Q J Almeida [Canada] | Insight into dopamine-dependent planning deficits in Parkinson's disease: A sharing of cognitive & sensory resources. |
| 000429 (2016) |
Serdar Durdagi [Turquie] ; Ramin Ekhteiari Salmas [Turquie] ; Matthias Stein [Allemagne] ; Mine Yurtsever [Turquie] ; Philip Seeman | Binding Interactions of Dopamine and Apomorphine in D2High and D2Low States of Human Dopamine D2 Receptor Using Computational and Experimental Techniques. |
| 000449 (2016) |
Michael D. Staudt [Canada] ; Andrea R. Di Sebastiano ; Hu Xu ; Mandar Jog ; Susanne Schmid ; Paula Foster ; Matthew O. Hebb | Advances in Neurotrophic Factor and Cell-Based Therapies for Parkinson's Disease: A Mini-Review. |
| 000470 (2015) |
Doris E. Payer [Canada] ; Mark Guttman ; Stephen J. Kish ; Junchao Tong ; Antonio Strafella ; Martin Zack ; John R. Adams ; Pablo Rusjan ; Sylvain Houle ; Yoshiaki Furukawa ; Alan A. Wilson ; Isabelle Boileau | [¹¹C]-(+)-PHNO PET imaging of dopamine D(2/3) receptors in Parkinson's disease with impulse control disorders. |
| 000570 (2015) |
Y. Wang [Canada] ; Z. Zhou [Canada] ; T. Leylek [Canada] ; H. Tan [Canada] ; Y. Sun [Canada] ; F E Parkinson [Canada] ; J-F Wang [Canada] | Protein cysteine S-nitrosylation inhibits vesicular uptake of neurotransmitters. |
| 000573 (2015) |
M. Yue [États-Unis] ; K. Hinkle [États-Unis] ; P. Davies [Royaume-Uni] ; E. Trushina [États-Unis] ; F. Fiesel [États-Unis] ; T. Christenson [États-Unis] ; A. Schroeder [États-Unis] ; L. Zhang [États-Unis] ; E. Bowles [États-Unis] ; B. Behrouz [États-Unis] ; S. Lincoln [États-Unis] ; J. Beevers [États-Unis] ; A. Milnerwood [Canada] ; A. Kurti [États-Unis] ; P. J. Mclean [États-Unis] ; J. D. Fryer [États-Unis] ; W. Springer [États-Unis] ; D. Dickson [États-Unis] ; M. Farrer [Canada] ; H. Melrose [États-Unis] | Progressive dopaminergic alterations and mitochondrial abnormalities in LRRK2 G2019S knock in mice |
| 000610 (2015) |
Jihye Park [Corée du Sud] ; Chae-Seok Lim [Corée du Sud] ; Hyunhyo Seo [Corée du Sud] ; Chung-Ah Park [Corée du Sud] ; Min Zhuo [Canada] ; Bong-Kiun Kaang [Corée du Sud] ; Kyungmin Lee [Corée du Sud] | Pain perception in acute model mice of Parkinson’s disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) |
| 000642 (2015) |
I. Aracil-Bola Os [Canada] ; A. P. Strafella [Canada] | Molecular imaging and neural networks in impulse control disorders in Parkinson’s disease |
| 000648 (2015) |
Yueting Shao [Canada] ; Daniel Figeys ; Zhibin Ning ; Ryan Mailloux ; Hing Man Chan | Methylmercury can induce Parkinson's-like neurotoxicity similar to 1-methyl-4- phenylpyridinium: a genomic and proteomic analysis on MN9D dopaminergic neuron cells. |
| 000665 (2015) |
Dayne A. Beccano-Kelly ; Mattia Volta ; Lise N. Munsie ; Sarah A. Paschall ; Igor Tatarnikov ; Kimberley Co ; Patrick Chou ; Li-Ping Cao ; Sabrina Bergeron ; Emma Mitchell ; Heather Han ; Heather L. Melrose [États-Unis] ; Lucia Tapia ; Lynn A. Raymond [Canada] ; Matthew J. Farrer ; Austen J. Milnerwood [Canada] | LRRK2 overexpression alters glutamatergic presynaptic plasticity, striatal dopamine tone, postsynaptic signal transduction, motor activity and memory. |
| 000709 (2015) |
Emily M. Rocha [États-Unis] ; Gaynor A. Smith [États-Unis] ; Eric Park [États-Unis] ; Hongmei Cao [États-Unis] ; Eilish Brown [États-Unis] ; Melissa A. Hayes [États-Unis] ; Jonathan Beagan [États-Unis] ; Jesse R. Mclean [États-Unis] ; Sarah C. Izen [États-Unis] ; Eduardo Perez-Torres [États-Unis] ; Penelope J. Hallett [États-Unis] ; Ole Isacson [États-Unis] | Glucocerebrosidase gene therapy prevents α-synucleinopathy of midbrain dopamine neurons. |
| 000849 (2015) |
Daryl J. Wile [Canada] ; Katie Dinelle [Canada] ; Nasim Vafai [Canada] ; Jessamyn Mckenzie [Canada] ; Joseph K. Tsui [Canada] ; Paul Schaffer [Canada] ; Yu-Shin Ding [États-Unis] ; Matthew Farrer [Canada] ; Vesna Sossi [Canada] ; A. Jon Stoessl [Canada] | A Scan Without Evidence Is Not Evidence of Absence: Scans Without Evidence of Dopaminergic Deficit in a Symptomatic Leucine-Rich repeat Kinase 2 Mutation Carrier |
| 000851 (2015) |
Beryl Luk [Canada] ; Mohinuddin Mohammed [Canada] ; Fang Liu [Canada] ; Frank J. S. Lee [Canada] | A Physical Interaction between the Dopamine Transporter and DJ-1 Facilitates Increased Dopamine Reuptake |
| 000936 (2014) |
Leigh Christopher [Canada] ; Sarah Duff-Canning [Canada] ; Yuko Koshimori [Canada] ; Barbara Segura [Canada, Espagne] ; Isabelle Boileau [Canada] ; Robert Chen [Canada] ; Anthony E. Lang [Canada] ; Sylvain Houle [Canada] ; Pablo Rusjan [Canada] ; Antonio P. Strafella [Canada] | Salience Network and Parahippocampal Dopamine Dysfunction in Memory-Impaired Parkinson Disease |
| 000959 (2014) |
Jackalina M. Van Kampen [Canada] ; David Baranowski [Canada] ; Denis G. Kay [Canada] | Progranulin Gene Delivery Protects Dopaminergic Neurons in a Mouse Model of Parkinson’s Disease |
| 000A13 (2014) |
Nadine Schweizer [Suède] ; Stéfano Pupe [Suède, Brésil] ; Emma Arvidsson [Suède] ; Karin Nordenankar [Suède] ; Casey J. A. Smith-Anttila [Suède] ; Souha Mahmoudi [Canada] ; Anna Andrén [Suède] ; Sylvie Dumas [France] ; Aparna Rajagopalan [Suède] ; Daniel Lévesque [Canada] ; Richardson N. Leão [Suède, Brésil] ; Sa Wallén-Mackenzie [Suède] | Limiting glutamate transmission in a Vglut2-expressing subpopulation of the subthalamic nucleus is sufficient to cause hyperlocomotion |
| 000A22 (2014) |
Christian Pifl [Autriche] ; Alex Rajput [Canada] ; Harald Reither [Autriche] ; Javier Blesa ; Carmen Cavada [Espagne] ; José A. Obeso ; Ali H. Rajput [Canada] ; Oleh Hornykiewicz [Autriche] | Is Parkinson's disease a vesicular dopamine storage disorder? Evidence from a study in isolated synaptic vesicles of human and nonhuman primate striatum. |
| 000A23 (2014) |
Sang Soo Cho [Canada] ; Yuko Koshimori [Canada] ; Kelly Aminian [Canada] ; Ignacio Obeso [Canada] ; Pablo Rusjan [Canada] ; Anthony E. Lang [Canada] ; Zafiris J. Daskalakis [Canada] ; Sylvain Houle [Canada] ; Antonio P. Strafella [Canada] | Investing in the Future: Stimulation of the Medial Prefrontal Cortex Reduces Discounting of Delayed Rewards |
